Stitch Fix stock maintains Neutral rating at UBS on margin concerns

Stitch Fix (SFIX) reported Q4 earnings and revenue beats, marking its second consecutive quarter of revenue growth after a multi-year decline, yet analyst sentiment remains divided. UBS maintained a Neutral rating and $6.00 price target, expressing concern that revenue growth is coming at the expense of gross margins (44.42%) and questioning the company's ability to stabilize them. Conversely, Bernstein raised its price target to $6.00 (Market Perform), while Mizuho maintained an Underperform rating with a $3.00 target despite acknowledging turnaround progress. The stock has declined over 15% in the past week to $4.56, reflecting investor caution amidst these mixed signals and margin pressures.

Analysis

Stitch Fix (SFIX) reported a second consecutive quarter of revenue growth, a notable shift after over three years of declines, with Q4 revenue of $311.2 million beating estimates by 2.14% and an EPS of -$0.07 surpassing forecasts by 30%. Despite these positive top- and bottom-line beats, analyst sentiment remains deeply divided and cautious. UBS maintained its Neutral rating and $6.00 price target, expressing significant concern that the nascent revenue recovery is being achieved at the expense of gross margins. The firm lacks conviction that management can successfully stabilize margins while sustaining revenue progress, a key catalyst required for a higher valuation. This cautious view is reinforced by the stock's recent performance, having declined over 15% in the past week to $4.56, and the potential downside risk from a weaker-than-expected holiday season. While Bernstein raised its price target to $6.00 in response to the positive trend, it maintained a Market Perform rating. Mizuho remains the most bearish, reiterating an Underperform rating with a $3.00 price target, even while acknowledging progress in the company's turnaround efforts and the potential of new AI tools.

Key Decisions for Investors

• Investors should weigh the positive signal of a second consecutive revenue beat against the critical risk of margin erosion, as the market's negative reaction suggests profitability concerns are outweighing top-line momentum.
• Monitor upcoming gross margin trends and holiday season guidance closely, as any sign of margin stabilization would be a significant bullish catalyst, while continued pressure would validate the current cautious analyst consensus.
• Given the wide divergence in analyst price targets ($3.00 to $6.00) and the stock's recent sharp decline despite positive results, a cautious or neutral stance may be prudent until the company demonstrates a clear path to balancing growth with profitability.